XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.4
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF LOSS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
3 Months Ended
Oct. 31, 2024
Oct. 31, 2023
EXPENSES    
Accretion expense $ 29,859 $ 30,113
Consulting 55,106 52,583
Directors' fees 30,000 28,022
Filing and regulatory 23,997 12,907
Foreign exchange loss 2,127 12,987
General and administrative 74,365 145,159
Geological, mineral, and prospect costs 45,162 361,525
Interest expense 96,201 63,543
Professional fees 100,881 337,541
Promotion and shareholder communication 8,187 20,011
Salaries 0 84,301
Share-based compensation 162,508 90,361
Loss (628,393) (1,239,053)
Loss on fair value adjustment on derivative liability 0 (82,481)
Write-off of receivable 0 (64,438)
Other income 0 7,547
Net loss and comprehensive loss for the period $ (628,393) $ (1,378,425)
Basic loss per common share $ (0.01) $ (0.03)
Diluted loss per common share $ (0.01) $ (0.03)
Weighted average number of common shares outstanding (basic) (in shares) 55,785,106 40,362,800
Weighted average number of common shares outstanding (diluted) (in shares) 55,785,106 40,362,800